AGAP13P

Across TCGA pan-cancer cohorts, AGAP13P RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated AGAP13P data layer compared with 1 for mutation status.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher AGAP13P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated AGAP13P expression acts as an unfavorable survival marker, although some lineages such as KIRP and HNSC show a favorable association.

KIRC, KIRP, and HNSC are the cancer types where AGAP13P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Median	All	0.509	0.708	<.001	134	view →
KIRP	OS	Tertile	All	0.982	0.882	.002	43	view →
HNSC	DFS	Quartile	IV	0.779	0.605	.011	36	view →
ACC	DFS	Median	All	0.421	0.801	.001	32	view →
BLCA	DFS	Quartile	III,IV	0.416	0.241	.002	29	view →
PAAD	DFS	Quartile	II,III,IV	0.595	0.249	.001	28	view →
LGG	OS	Median	All	0.865	0.756	<.001	23	view →
GBM	DFS	Median	All	0.390	0.187	<.001	21	view →
THYM	DFS	Quartile	II,III,IV	1.000	0.441	.003	13	view →
LIHC	DFS	Quartile	All	0.435	0.585	.007	13	view →
PRAD	OS	Median	All	0.825	0.935	.014	10	view →
UVM	DFS	Quartile	All	0.270	0.776	.040	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

AGAP13P–KIRC (OS)

Open the KIRC breakdown →